BNTC - Benitec Bio secures $13M capital via equity offering
Benitec Biopharma's (BNTC) underwriter has agreed to increase the size of the previous offering and purchase on a firm commitment basis ~3M shares of common stock at $4.25/share.Expected gross proceeds are ~$12.9MUnderwriter's over-allotment is an additional ~455.5K shares. Net proceeds will be used for development activities for its product pipeline, general corporate purposes, and strategic growth opportunities.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.Closing date is April 30.shares down 20.4% after-hours. Yesterday's close was $5.48.
For further details see:
Benitec Bio secures $13M capital via equity offering